Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610272200 on January 24, 2007

J. Biol. Chem., Vol. 282, Issue 11, 8545-8556, March 16, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/11/8545    most recent
M610272200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, M.
Right arrow Articles by Henderson, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, M.
Right arrow Articles by Henderson, B. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IQ-domain GTPase-activating Protein 1 Regulates beta-Catenin at Membrane Ruffles and Its Role in Macropinocytosis of N-cadherin and Adenomatous Polyposis Coli*Formula

Manisha Sharma and Beric R. Henderson1

From the Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute at Westmead Hospital, Westmead, New South Wales 2145, Australia

Received for publication, November 3, 2006 , and in revised form, January 8, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
beta-Catenin is an integral component of E-cadherin dependent cell-cell junctions. Here we show that beta-catenin co-localizes with IQ-domain GTPase-activating protein 1 (IQGAP1), adenomatous polyposis coli (APC), and N-cadherin at actin-positive membrane ruffles in NIH 3T3 fibroblasts. We used deletion mapping to identify the membrane ruffle-targeting region of beta-catenin, localizing it to amino acids 47-217, which overlap the IQGAP1 binding site. Knockdown by small interference RNA (siRNA) revealed IQGAP1-dependent membrane targeting of beta-catenin, APC, and N-cadherin. Transient overexpression of IQGAP1 or N-cadherin increased beta-catenin at membrane ruffles. IQGAP1/APC regulates cell migration, and using a wound healing assay we demonstrate that siRNA-mediated loss of beta-catenin also caused a modest reduction in the rate of cell migration. More significantly, we discovered that beta-catenin is internalized by Arf6-dependent macropinocytosis near sites of membrane ruffling. The beta-catenin macropinosomes co-stained for APC, N-cadherin, and to a lesser extent IQGAP1, and internalization of each binding partner was abrogated by siRNA-dependent knockdown of beta-catenin. In addition, beta-catenin macropinosomes co-localized with the lysosomal marker, lysosome associated membrane protein 1, consistent with their recycling by the late endosomal machinery. Our findings expand on current knowledge of beta-catenin function. We propose that in motile cells beta-catenin is recruited by IQGAP1 and N-cadherin to active membrane ruffles, wherein beta-catenin mediates the internalization and possible recycling of the membrane-associated proteins N-cadherin and APC.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
beta-Catenin is a multifunctional protein with roles in cell-cell adhesion and as a mediator of nuclear signaling in the Wnt pathway and in various types of cancer (1). beta-Catenin is involved in cell adhesion through its interaction with E-cadherin at cell-cell junctions (2), and as a transcriptional activator it binds/activates the lymphoid enhancing factor-1/T-cell factor transcription factors to induce genes involved in cell transformation (3). Cytoplasmic beta-catenin is normally subject to strict regulation by the APC2/axin/glycogen synthase kinase-3beta degradation complex, which promotes beta-catenin turnover through the proteasome (1). Disruption of beta-catenin degradation results in increased beta-catenin protein levels and an altered distribution of beta-catenin, which shifts from membrane and cytoplasm to the nucleus, culminating in changes typical of the transformed cellular phenotype including enhanced cell migration and increased proliferation. Despite an increase in our knowledge concerning beta-catenin subcellular distribution, nuclear transport, and turnover (3, 4), our understanding of how membrane-associated beta-catenin is internalized and recycled is rather poor.

Membrane-localized beta-catenin is mostly bound to E-cadherin at adherens junctions, structures that mediate cell-cell adhesion and maintain epithelial cell contact, polarity, and communication (5). The adherens junctions are positioned at the basolateral membrane, and their formation is dependent on the homophilic binding of the transmembrane protein E-cadherin. beta-Catenin together with {alpha}-catenin tethers adherens junctions to the actin cytoskeleton (2, 6). The formation and disassembly of adherens junctions is a dynamic process linked to tissue remodeling and tumor cell invasion (7). The loss of adherens junctions can result in disruption of apical-basal polarity and loss of the epithelial phenotype and is a contributing factor to the so-called epithelial-to-mesenchymal transition, a shift in cellular phenotype associated with the progression of epithelial-derived cancers (8). The loss of beta-catenin and E-cadherin from the cell surface is emerging as a key event in this process, especially in breast and colon carcinomas where E-cadherin down-regulation occurs through multiple mechanisms (7-9). In addition to the reduced anchorage of cells caused by loss of E-cadherin, they can also acquire a more migratory phenotype through the release of beta-catenin from the membrane and its translocation to the nucleus, where it activates genes involved in cell transformation and migration (1, 3).

More recently, a second membrane localization of cellular beta-catenin was reported. Etienne-Manneville et al. (10) showed that beta-catenin was detectable at the leading edge of migrating rat astrocytes; however, this localization pattern has not yet been confirmed or characterized. Although it is possible this atypical membrane staining pattern reflected artifactual antibody staining, it is equally plausible that beta-catenin does localize to lamellipodia and active ruffling membrane in mesenchymal cells or fibroblasts. The appearance of the beta-catenin binding partner, APC, was recently reported at such dynamic membrane structures (11), and the membrane association of APC was functionally linked to cell migration. In this study we performed a series of experiments that provide compelling evidence for the localization of beta-catenin at membrane ruffles. We further show that membrane-associated beta-catenin correlates with a modest contribution to cell migration and that this unexpected localization pattern is important for the internalization of beta-catenin and specific binding partners through the process of macropinocytosis. We identified IQGAP1, an important regulator of actin dynamics and cell migration (11, 12), as a key regulator of beta-catenin at the membrane.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture, Reagents, and Transfection—The following cell lines were used: non-tumor derived epithelial cell lines (canine kidney epithelial cells), HEK-293T (immortalized human embryonic kidney cells), and MCF10A (breast epithelial cell line); breast tumor epithelial cell lines T47D, MCF-7, and MDA.MB.231; mouse fibroblast cell line NIH 3T3. All cell lines were confirmed mycoplasma-free and were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics (penicillin and streptomycin) at 37 °C in 5% CO2 humidified atmosphere. For transfection cells were grown on glass coverslips in 8-well dishes (Nunc) and 12 h post-seeding were transfected with 2 µg of DNA or 3 µg of siRNA per ml of media using Lipofectamine 2000 (Invitrogen); the lipid-DNA mix was left on cells for 6 h before replacing the medium and processing cells 40 h later. Cells were processed for microscopy or wound healing assay. The effect of ARF6 was studied by treating the cells with 30 µM Myr-Arf6 peptide (Calbiochem) for 1 h.

Plasmids—The following plasmids were transfected into NIH 3T3 cells: pEGFP-Rac1 and pEGFP-RhoA constructs were gifts from Dr. Mark Philips (13); human pEGFP-E-cadherin was a gift from Dr. Alpha Yap; murine pEGFP-N-cadherin was a gift from Dr. C. Gauthier-Rouvière; human pASEF-wt and pASEF-ca were gifts from Prof. Tetsu Akiyama (14, 15); human pEGFP-IQGAP-wt and -ct (amino acids 1503-1657) were gifts from Dr. Kozo Kaibuchi (11). Human beta-catenin-wt-FLAG plasmid and beta-catenin-{Delta}218-467-FLAG plasmid were gifts from Dr. Eric Fearon (16) and were used as templates to construct a set of beta-catenin-GFP vectors in the expression plasmid pEGFP-N1 (Clontech). The beta-catenin cDNA insert sequences were PCR-amplified using forward and reverse primers (see Table 1) containing KpnI site (in forward primer) and BamH1 (in reverse primer) restriction sites and cloned in-frame into pEGFP-N1. beta-Catenin-wt-FLAG plasmid was used as template for all constructs except beta-catenin-{Delta}218-467-GFP, where beta-catenin-{Delta}218-467-FLAG was used as the template. All clones were confirmed by sequencing.


View this table:
[in this window]
[in a new window]

 
TABLE 1
Primers used for cloning beta-catenin-GFP plasmids

 
Immunofluorescence Microscopy, Confocal Microscopy, and Antibodies—Cells were washed with PBS and fixed with 3.7% formalin, PBS for 20 min followed by permeabilization with 0.2% Triton-X-100, PBS for 10 min. Cells were blocked with 3% bovine serum albumin, PBS for 45 min, incubated with 150 µl of primary antibody (diluted in blocking solution; see below for dilutions), and washed 3 times with PBS. Cells were subsequently incubated with secondary antibody. All incubations were carried out at room temperature. After extensive washes in PBS, slides were mounted with Vectashield (Vector Labs) and visualized by fluorescence microscopy. The following antibodies were used for immunofluorescence labeling and Western blotting: beta-catenin polyclonal antibody (1:100, Santa Cruz Biotechnology, Inc., #H102), beta-catenin monoclonal antibody (1:100, Transduction Laboratories #610153), M-APC rabbit polyclonal antibody (a gift from Dr. Inke Nathke), N-cadherin monoclonal antibody (1:100, Zymed Laboratories Inc. #33-3900), IQGAP1 polyclonal antibody (1:100, Santa Cruz, H109), IQGAP1 monoclonal antibody (1:100, Transduction Laboratories, #610612), clathrin monoclonal antibody (1:100, Transduction Laboratories #610499), anti-HA (1:200, Santa Cruz, clone Y-11), Arf6 monoclonal antibody (1:100, Santa Cruz, clone 3A-1), beta-actin monoclonal antibody (1:5000, Sigma clone AC-74), Rab 3A polyclonal antibody (1:100, Santa Cruz, clone K-15), Rab5 (1:100, Transduction Laboratories #610281), EEA1 polyclonal antibody (1:100, Santa Cruz clone C-15), LAMP1 monoclonal antibody (1:200, Transduction Laboratories #611042), Rab11 monoclonal antibody (1:100, Transduction Labs #610656), TGN38 (1:200, Transduction Laboratories, #610898), beta-COP (1:2000, Affinity Bioreagents #PA1-061), TRITC- or FITC-conjugated phalloidin (0.5 µg/ml, Sigma P1951 or P5282, respectively). Secondary antibodies used were anti-mouse or anti-rabbit antibody conjugated to biotin (1:500, DAKO), Texas Red conjugated to avidin (1:800, Vecta Laboratories), anti-mouse conjugated to FITC (1:100, Santa Cruz), or anti-rabbit conjugated to FITC (1:100, Santa Cruz). Confocal microscope images of labeled cells were taken at x600 magnification using the Leica TCS SP2 confocal system attached to a Leica upright fluorescence microscope (DMRE) and using Leica Confocal Software Version 2.00. Other images were taken using an Olympus BL51 fluorescence microscope at x400 magnification. A SPOT 32 camera and SPOT Advanced software was used for general image capture. The images were modified in Adobe Photoshop 7.0.

Deconvolution Analysis of Microscope Images—For high resolution imaging of cells, an inverted Zeiss Axiovert 200M microscope was used to capture 21 sections of cell samples, each section of 0.35 µm, a z axis range that spanned the apical to basal part of the cell. Images were resolved by iterative deconvolution using the Zeiss software inverse filter algorithm. The deconvolved images selected for presentation in this study correspond to sections 10-15 and represent a mid-plane transsection of the cell.

Dextran Labeling Experiment—For uptake of dextran-FITC (71 kDa; Sigma) or dextran-TRITC (76 kDa; Sigma), cells were transfected with ASEF-ca plasmid. After 30 h cells were incubated with 4 mg/ml dextran for 15 min to 1 h at 37 °C in serum-free media followed by 3 washes with fresh media and PBS (17). Cells were then fixed with 3.7% formalin, stained with beta-catenin monoclonal antibody or M-APC polyclonal antibody, and analyzed by Zeiss deconvolution microscopy as described above.

Western Blot Analysis—Cells were resuspended in protein extraction buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, supplemented with protease inhibitor mix (Roche Diagnostics) and shock-frozen in liquid nitrogen. After a quick thaw at 37 °C, cells were refrozen in liquid nitrogen, thawed on ice for 20 min, and cleared of insoluble components by centrifugation at 13,000 rpm at 4 °C for 15 min. The supernatant containing total protein was quantified using the Bio-Rad protein assay. Cell extracts were then denatured at 95 °C for 5 min in sample buffer (100 mM Tris-HCl, pH 6.8, 20% glycerol, 0.01% bromphenol blue, 10% beta-mercaptoethanol, 5% SDS), and 40 µg of proteins were separated on a 7.5% SDS-poly-acrylamide gel and transferred onto nitrocellulose membranes (Millipore). Membranes were treated in blocking solution (5% dry milk in PBS containing 0.2% Tween 20) and incubated with primary antibody at room temperature for 2 h followed by incubation with horseradish peroxidase-conjugated secondary antibody (1:5000; Sigma) for 1 h at room temperature. Proteins were visualized by ECL (Amersham Biosciences). Prestained broad range molecular weight marker (Bio-Rad) was used as the molecular size standard.

RNA Interference—Double-stranded 21-mer RNA oligonucleotides homologous to sequences in mouse IQGAP1 or beta-catenin (see Table 2) were purchased as purified duplexes (Qiagen-Xeragon Inc). Cells at medium density were transfected with 3 µg of RNA duplexes in 1 ml of Dulbecco's modified Eagle's medium using Lipofectamine for 6 h and either harvested 48 h post-transfection for image analysis or analyzed by time-lapse microscopy.


View this table:
[in this window]
[in a new window]

 
TABLE 2
siRNA sequences used in this study

 
Wound Healing Assay—NIH 3T3 cells were grown on 4-well chamber slides (Lab-Tek, #155383). After 72 h, the confluent cells were wounded using a Gilson P1000 pipette tip. Cells were imaged live along the wound at 8 different regions per well for 15 h using a Zeiss Axiovert 200M inverted microscope. For each region, the distance migrated by cells was measured at three different points. Thus, for each well the distance migrated was recorded as an average of 24 points every hour. At the end of the time-lapse experiment cells were fixed and stained with beta-catenin and Texas Red-conjugated secondary antibody and FITC-conjugated phalloidin to confirm knock-down of the beta-catenin. The assay was repeated twice.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
beta-Catenin Is Localized at Membrane Ruffles in Migrating Cells—Our laboratory has an ongoing interest in the subcellular localization and intracellular trafficking of beta-catenin (18-20). The steady-state localization of beta-catenin in the nucleus and at cell-cell junctions is well documented (1). beta-Catenin has been reported at cell membrane lamellipodia (10), and we have detected beta-catenin at lamellipodia, filopodia, and short membrane ruffles; however, such localization patterns remain poorly characterized. We tested for non-adherens junction membrane staining of beta-catenin in a panel of cell lines using the wound healing assay, which permits analysis of actively migrating cells. Confluent monolayers of different epithelial cell lines were scratched and allowed to heal for 6 h then immunostained with antibody to beta-catenin and with fluorescent-tagged phalloidin to detect actin (Fig. 1A and supplemental Fig. S1). In canine kidney epithelial cells, visible beta-catenin was primarily restricted to cell-cell junctions, consistent with the fact that these cells form extremely tight and stable cell-cell junctions and are not highly motile. In the breast cancer epithelial cell lines T47D and MCF-7, beta-catenin was detected both at cell-cell junctions and also at membrane ruffles in migrating cells at the wound edge. The staining of beta-catenin was more biased toward actin-positive membrane ruffles in NIH 3T3 fibroblasts (Fig. 1B). To confirm specificity of the membrane staining of beta-catenin, we treated NIH 3T3 cells with siRNA to silence beta-catenin and observed a consequent loss of staining from cell-cell junctions, the nucleus and cytoplasm, and also from the membrane ruffles. In contrast, a control siRNA had no effect on beta-catenin staining patterns, and the actin staining pattern was unaffected, indicating that membrane ruffles are a genuine site of beta-catenin accumulation.

To further test the localization of beta-catenin at membrane ruffles, we transfected NIH 3T3 cells with plasmids encoding different factors known to modulate actin dynamics and induce membrane ruffling; a constitutively active form of Rac1 GTPase (13, 21), the Rac1 GTPase exchange factor, ASEF (14) and a constitutively active form of ASEF (15), and stained cells for actin and beta-catenin. Both Rac1 and ASEF increased the proportion of transfected cells with actin-positive membrane ruffles by 1.5-2.5-fold, and a corresponding increase in cellular beta-catenin was detected at these membrane structures (Fig. 1C). The strongest effect was elicited by constitutively active ASEF (ASEF-ca), which induced a 3-fold increase in actin-positive ruffles and a 2.5-fold increase in beta-catenin-positive ruffles. Thus, the localization of beta-catenin at membrane ruffles is associated with induction of these migratory structures.


Figure 1
View larger version (59K):
[in this window]
[in a new window]

 
FIGURE 1.
beta-Catenin localizes at membrane ruffles. A, different epithelial cell lines were grown to confluence and wounded. Cells were allowed to heal for 6 h then immunostained withbeta-catenin monoclonal antibody and Texas Red secondary conjugate to detect membrane staining by fluorescence microscopy. MDCK, Madin-Darby canine kidney cells. B, NIH 3T3 cells were transfected with control (top panel) and beta-catenin (bottom panel) siRNA. 48 h later confluent cells were wounded, and the cells were allowed to heal for 6 h before fixation and staining for beta-catenin (as above) and actin (fluorescein-labeled phalloidin). The % of actin ruffle-positive cells displaying beta-catenin positive membrane ruffles after each siRNA treatment is shown in the graph. C, beta-catenin localizes to ASEF-induced membrane ruffles. NIH 3T3 cells were transfected with HA-tagged ASEF (wild-type or constitutively active forms), GFP, or GFP-Rac1L61 expression plasmids. At 30 h post-transfection, cells were immunostained with anti-HA antibody (for ASEF-transfected cells) and Alexa Fluor-488-conjugated secondary antibody, with beta-catenin and Texas Red-conjugated secondary antibody or TRITC-conjugated phalloidin. Cell images are shown in the left panel, and quantification of ASEF-ca-transfected cells for localization of beta-catenin or actin at membrane ruffles is shown at the right. The values are the mean ± S.E. from 2-3 experiments, scoring at least 100 cells per slide.

 
beta-Catenin Co-localizes with IQGAP1, APC, and N-cadherin at Membrane Ruffles—NIH 3T3 cells were transfected with ASEF-ca plasmid to induce membrane ruffles then stained for beta-catenin and three partner proteins previously reported to locate at membrane ruffles (Fig. 2A). Cells positive for beta-catenin were compared for the extent to which beta-catenin co-located with each partner at ruffles (Fig. 2A and supplemental Fig. S2). IQGAP1 is a known marker protein of membrane ruffles (22). We detected co-localization of IQGAP1 or actin in ~97% of NIH 3T3 cells with beta-catenin-positive ruffles. Watanabe et al. (11) showed that IQGAP1 recruits APC to membrane ruffles. We, therefore, stained for APC protein (using M-APC antibody) and found that 62% of cells with beta-catenin-positive membrane ruffles co-stained with APC. We next tested beta-catenin-positive membrane ruffles for the presence of N-cadherin, a transmembrane protein and binding partner of beta-catenin previously observed at free membrane and implicated in cell migration and invasion (23). A high degree of co-localization was observed between these two proteins at membrane ruffles (95% of cells analyzed). Other membrane proteins such as E-cadherin and Zo-1 displayed poor co-staining with beta-catenin at ruffles (see supplemental Fig. S3). We conclude that beta-catenin-positive membrane ruffles co-localize with actin, IQGAP1, APC, and N-cadherin.

Transiently Expressed N-cadherin and IQGAP1 Increase beta-Catenin at Membrane Ruffles—In contrast to APC, which regulates beta-catenin turnover (1, 3), N-cadherin and IQGAP1 independently locate at free membrane and are potential regulators of beta-catenin targeting to membrane ruffles. Indeed, when transiently expressed in cells, GFP-tagged forms of both N-cadherin and IQGAP1 stimulated beta-catenin staining at ruffles relative to the effect seen with E-cadherin (Fig. 2, B and C) or a GFP control (Fig. 1 and supplemental Fig. S4).


Figure 2
View larger version (35K):
[in this window]
[in a new window]

 
FIGURE 2.
beta-Catenin co-localizes with IQGAP1, APC, and N-cadherin at membrane ruffles. A, NIH 3T3 cells were transfected with pASEF-ca (but not stained) and immunostained for endogenous beta-catenin and its partner proteins IQGAP1, APC, and N-cadherin. Cells were analyzed by fluorescence microscopy as shown. The % cells showing co-localization with partner proteins is shown at right. B, NIH 3T3 cells were transfected with plasmids encoding GFP-tagged E-cadherin, N-cadherin (50), and IQGAP1 (11) and stained for beta-catenin. C, the % cells with beta-catenin at ruffles was scored and graphed as the mean ± S.E. Data are from two experiments scoring ~200 cells per sample.

 


Figure 3
View larger version (48K):
[in this window]
[in a new window]

 
FIGURE 3.
beta-Catenin localization at membrane ruffles requires amino acids 47-217. A, schematic diagram of beta-catenin constructs compared for subcellular localization. The IQGAP1 and APC/N-cadherin binding domains of beta-catenin are indicated. B, NIH 3T3 cells were co-transfected with pASEF-ca-HA and different beta-catenin-GFP constructs. After 30 h cells were immunostained with anti-HA antibody and Texas Red conjugate secondary antibody. 200 co-transfected cells were scored per slide for the localization of ASEF and beta-catenin-GFP at membrane ruffles. Values shown are mean ± S.E. from two experiments. C, representative microscopy images of membrane staining for transiently expressed ASEF and beta-catenin-GFP fusions.

 
The IQGAP1 Binding Region (Amino Acids 47-217) Is Required for beta-Catenin Localization to Membrane Ruffles—We next investigated the sequences that are necessary to target beta-catenin to membrane ruffles. To address this, NIH 3T3 cells were transfected with a series of GFP-tagged beta-catenin deletion constructs (Fig. 3A) and co-expressed with pASEF-ca to elicit membrane ruffling. We scored transfected cells for the localization of ectopic ASEF-ca and beta-catenin-GFP. Wild-type beta-catenin localized to ASEF-positive membrane ruffles in 25% of transfected cells, displaying ~80% co-localization with ASEF at ruffles (Fig. 3, B and C). Deletion of amino acids 1-47, the primary phosphorylated sequence of beta-catenin, did not change its localization at membrane ruffles, suggesting that phosphorylation per se is not required for membrane localization. Subsequent deletion of residues 1-132 reduced beta-catenin localization at membrane ruffles by ~40%, whereas deletion of amino acids 1-217 reduced this staining pattern by 75%.

Interestingly, an internal deletion of the arm domain (amino acids 218-467) that prevents binding to APC and N-cadherin did not impair beta-catenin localization at ruffles. Thus, although N-cadherin may boost beta-catenin at the free membrane, it is not essential. These results indicate that residues 47-217 are critical for localization of beta-catenin at membrane ruffles. This sequence contains the binding site for IQGAP1 (amino acids 123-183; Ref. 24), implicating IQGAP1 as a primary anchor or regulator of beta-catenin at membrane ruffles.


Figure 4
View larger version (36K):
[in this window]
[in a new window]

 
FIGURE 4.
IQGAP1 contributes to the localization of APC, beta-catenin, and N-cadherin at membrane ruffles. A, NIH 3T3 cells were transfected with control or IQGAP1 siRNA as detailed under "Materials and Methods." After 48 h total protein was extracted, and 40-µg samples were analyzed by Western blot using anti-IQGAP1 or actin monoclonal antibody. B, NIH 3T3 cells were transfected with control or IQGAP1 siRNA and immunostained with anti-IQGAP1 antibody and Texas Red-conjugated secondary antibody. The partner protein, APC, beta-catenin, or N-cadherin was immunostained with primary antibody and Alexa Fluor-488-conjugated antibody (images are shown here for beta-catenin staining). C, cells were scored for the presence of IQGAP1 (control siRNA cells) or absence of IQGAP1 (IQGAP1 siRNA) at membrane ruffles and the proportion of cells in each case that displayed membrane ruffle staining of the three partners. A total of 200-300 cells were scored for each sample, and values shown are the mean ± S.E. from two experiments.

 
Silencing IQGAP1 Expression Reduces beta-Catenin, APC, and N-cadherin at Membrane Ruffles—We examined the effect of silencing IQGAP1 expression in NIH 3T3 cells. Relative to cells treated with a control siRNA, endogenous IQGAP1 was reduced ~80% by an IQGAP1-specific siRNA as shown by Western blot (Fig. 4A). NIH 3T3 cells were transfected with control or IQGAP1 siRNA, and 48 h later cells were immunostained with antibodies against IQGAP1 and partner proteins. More than 200 cells were scored in each case, comparing cells that were either positive for IQGAP1 membrane ruffles (control siRNA group) or cells that were negative for IQGAP1-stained ruffles (IQGAP1 siRNA) as shown in Fig. 4B. Cells were subconfluent, and all displayed free membrane with the potential to form ruffles. We found that ~55% of cells that stained positive for IQGAP1 at membrane ruffles also stained positive for beta-catenin at these structures. In contrast, those cells negative for IQGAP1 at ruffles showed only ~20% staining of beta-catenin at ruffles. The loss of IQGAP1 did not result in a net loss of ruffle formation as revealed by staining for actin-positive ruffles, which was unaffected by IQGAP1 knock-down (data not shown). Moreover, siRNA-dependent silencing of APC, although less efficient in NIH 3T3 cells (50% of cells with loss of APC ruffles), caused an increase in beta-catenin nuclear staining but had no significant affect on beta-catenin at membrane ruffles (data not shown). We, therefore, conclude that IQGAP1 contributes to recruitment of beta-catenin at ruffling membrane. A similar conclusion was proposed by Watanabe et al. (11) for the effect of IQGAP1 on APC in human Vero fibroblasts. Indeed, we confirmed the ability of IQGAP1 siRNA to facilitate a similar loss of APC in NIH 3T3 cells. Furthermore, we observed an unexpected and novel inhibitory effect of IQGAP1 siRNA on staining of N-cadherin at membrane ruffles (Fig. 4C). These data indicate a role for IQGAP1 in recruiting not only APC but also beta-catenin and N-cadherin to membrane ruffles.

Silencing of beta-Catenin Reduces APC and N-cadherin, but Not IQGAP1, at Membrane Ruffles—NIH 3T3 cells were treated with beta-catenin siRNA, resulting in >90% specific loss of beta-catenin protein (Fig. 5A). These cells were then stained and assessed for protein localization at membrane ruffles as described above for the IQGAP1 knockdown (Fig. 4). We found that beta-catenin silencing had no effect on IQGAP1 at membrane ruffles, whereas it abolished staining of APC and N-cadherin in 40-50% of cells (Fig. 5B). These data indicate that IQGAP1 acts upstream of beta-catenin. The knockdown of either IQGAP1 or beta-catenin reduced APC and N-cadherin at ruffles, suggesting that IQGAP1 may co-operate with beta-catenin to enlist membrane recruitment of specific partners.

The Loss of beta-Catenin Retards Cell Migration in a Wound Healing Assay—We investigated the possibility that beta-catenin contributes to cell migration in a wound healing assay. NIH 3T3 cells were transfected with control or beta-catenin siRNA, and 72 h post-transfection cells were wounded, and cells at the wound edge were imaged by time-lapse microscopy. A Zeiss Axiovert 200M live cell imaging system was used to track 8 different wound regions every hour over a 15-h period. For each region three points were selected for post-image analysis, and the distance migrated by cells every hour was measured using Zeiss Axiovision software. After the wound-heal experiment, cells were fixed and stained for beta-catenin and actin to confirm the siRNA-mediated loss of beta-catenin. Using this approach we observed a slight retardation of wound healing in beta-catenin siRNA-transfected cells relative to control siRNA-treated cells (Fig. 6). The most consistent effect was observed within the first 6 h, suggesting that loss of beta-catenin slows the response to wounding and the initiation of cell movement. It has previously been suggested that beta-catenin might contribute to cell migration or invasion through its nuclear transcriptional activity; however, a transcription-independent link between beta-catenin and cell migration has also been suggested (23). We note that membrane ruffle-associated beta-catenin forms a significant fraction of the beta-catenin pool in migrating 3T3 cells, leading us to propose that the membrane-associated fraction of beta-catenin may contribute to cell migration in this assay. However, because the change in cell migration activity was relatively modest, it was evident that beta-catenin might in fact be recruited to membrane ruffles for another reason.


Figure 5
View larger version (35K):
[in this window]
[in a new window]

 
FIGURE 5.
siRNA silencing of beta-catenin reduces APC and N-cadherin at membrane ruffles. A, NIH 3T3 cells were transfected with control or beta-catenin siRNA, and efficacy of the beta-catenin knock-down was confirmed by Western blot as shown. B, cells transfected with control or beta-catenin siRNA were co-stained for IQGAP1, APC, or N-cadherin and scored for membrane ruffle staining (as shown in legend to Fig. 4). A total of 200-300 cells were scored for each sample, and values shown are the mean ± S.E. from two experiments.

 


Figure 6
View larger version (60K):
[in this window]
[in a new window]

 
FIGURE 6.
Silencing of beta-catenin slows cell migration. NIH 3T3 cells were treated with control or beta-catenin siRNA (as in Fig. 5). A, cells were allowed to reach confluence (72 h), then wounded and analyzed over a 15-h period. Migration of cells at the wound edge was recorded by time-lapse microscopy every hour using a Zeiss Axiovision 200M system (see "Materials and Methods"). The distance migrated by cells was measured at 24 distinct positions along the wound. The average distance migrated was plotted against time, with values shown representing the mean ± S.E. from two different experiments. B, representative phase contrast images of migrating cells at different times post wounding. Cells moved in the direction of arrows.

 
The Localization of beta-Catenin at Membrane Ruffles Triggers Its Internalization through Macropinocytosis—Membrane ruffles are associated not only with cell motility but also with the process of fluid phase protein uptake through macropinocytosis (25, 26). During our study we observed frequent staining of beta-catenin in large cytoplasmic particles, not only in NIH 3T3 cells, but also in breast cancer cell lines such as T47D and MCF-7 (see Fig. 7A and supplemental Fig. S5). We induced membrane ruffling in NIH 3T3 cells and noticed that the appearance of beta-catenin particles increased in proportion to the extent of membrane ruffling (see Fig. 7B). Indeed the proportion of cells with beta-catenin particles was 4-fold higher in cells that displayed membrane ruffles.

To determine whether the particles we observed are macropinosomes, we transfected NIH 3T3 cells with pASEF-ca and 48 h later incubated these cells with the fluid phase pinocytic marker, TRITC-conjugated dextran, then fixed the cells after 1 h and immunostained for beta-catenin. Deconvolution analysis of microscopy cell images was used to show that surface-labeled dextran was internalized from the membrane into the cytoplasm of the cells and that the internalized dextran co-localized with beta-catenin in the cytoplasmic particles (Fig. 7C). This is strong evidence that the beta-catenin is indeed being internalized by macropinocytosis at the site of membrane ruffles. We also observed co-localization between dextran and APC in macropinosome particles (Fig. 7C).

We further tested some breast tumor epithelial cell lines for the presence of beta-catenin macropinosomes. beta-Catenin was frequently observed at membrane ruffles and in macropinosomes. beta-Catenin macropinosomes were seen in 11-13% of cells in the cell lines T47D, MCF7, and MDA.MB.2321 (Fig. 7A and supplemental Fig. S5).

beta-Catenin Macropinocytosis Is Regulated by Arf6 GTPase—The Arf6 GTPase has been implicated in endocytosis and actin remodeling (27), E-cadherin internalization (28, 29), and macropinocytosis (17). Arf6 must cycle between GTP and GDP-bound forms to function properly, and the overexpression of either constitutively active or dominant negative mutants can inhibit its activity by preventing its GTP/GDP binding cycle (27). Palacois et al. (28) reported that GTP-bound Arf6 can induce disassembly of adherens junctions and the internalization/endocytosis of E-cadherin. They also observed Arf6-mediated ruffling of the lateral membrane, which is implicated in its role in facilitating macropinocytosis (30). We hypothesized that a block in the Arf6 GTPase cycle might affect macropinocytosis of beta-catenin in NIH 3T3 cells. To address this, we tested a myristoylated synthetic peptide corresponding to the N-terminal region of Arf6, which was previously reported to block Arf6 activities in various cellular processes including the aluminum fluoride induced activation of phospholipase D and release of beta-arrestin protein (31, 32). Cells were transfected with the ASEF-ca plasmid to induce ruffling, and 30 h later cells were treated with the myrArf6 (2-13) peptide and stained with antibodies against Arf6 and beta-catenin (Fig. 7D). Microscopic analysis revealed that Arf6 peptide treatment caused a 67% reduction in beta-catenin staining at membrane ruffles and in beta-catenin positive macropinosomes relative to vehicle-treated cells. A similar result was observed for human T47D breast cancer cells (see supplemental Fig. S6). We conclude that macropinocytosis of beta-catenin from membrane ruffles is regulated by Arf6 GTPase.


Figure 7
View larger version (59K):
[in this window]
[in a new window]

 
FIGURE 7.
beta-Catenin undergoes macropinocytosis at membrane ruffles. A, immunostaining of NIH 3T3 cells and T47D breast cancer cells revealed the frequent detection of beta-catenin-positive particles in the cytoplasm, often near the site of membrane ruffles. B, to determine whether the macropinosome-like particles correlated with membrane ruffling, NIH 3T3 cells were transfected with pEGFP or pASEF-ca, and the transfected cells were analyzed for both beta-catenin particles and membrane ruffle formation. Data shown are the mean ± S.E. from three experiments. Number cells scored shown in parentheses. C, to test if the beta-catenin particles co-stain with the uptake of fluid-phase fluorescent dextran, ASEF-transfected NIH 3T3 cells were incubated with dextran conjugated TRITC for 1 h and then stained with beta-catenin or M-APC antibodies and Alexa Fluor-488-conjugated secondary antibody. In each case 30 different z-stack images were captured at 0.3-µm step size collected on a Zeiss Axiovert 200M microscope and deconvolved using Zeiss software. This analysis confirmed co-localization of beta-catenin and APC with dextran in cytoplasmic macropinosomes. D, to test for regulation by Arf-6 GTPase, ASEF-transfected NIH 3T3 cells were treated with 33 µM myr-Arf6-peptide (2-13) or vehicle alone (Me2SO (DMSO)) for 1 h, stained with beta-catenin antibody, and then scored by microscopy for beta-catenin at membrane ruffles or in macropinosomes. Data shown are the mean ± S.E. from three experiments.

 
beta-Catenin Co-localizes with Actin, APC, N-cadherin, and IQGAP1 at Macropinosomes—The macropinocytosis of beta-catenin involves involution of membrane at sites of ruffling and might represent an avenue for internalization of those beta-catenin binding partners found to co-locate with beta-catenin at membrane ruffles (Fig. 2). To test this we transfected NIH 3T3 cells with pASEF-ca and stained cells for beta-catenin and the different partner proteins. A strong co-localization with beta-catenin (≥90%) was observed for actin and N-cadherin at macropinosomes (Fig. 8). Actin itself is known to coat macropinosomes early during internal transit (33), whereas the identification of N-cadherin is novel. Nearly 60% of beta-catenin macropinosomes co-localized with APC, whereas only 28% stained positive for IQGAP1. ASEF-ca protein provided a valuable internal control, and although it was present at membrane ruffles with beta-catenin, only 8% of beta-catenin macropinosomes displayed detectable ASEF protein. We propose that actin, APC, N-cadherin, and IQGAP1 are to varying degrees internalized from the membrane in macropinosomes along with beta-catenin.

IQGAP1 Regulates beta-Catenin Macropinocytosis—We scored for the presence of beta-catenin macropinosomes after knockdown of IQGAP1. An ~70% reduction in cells with beta-catenin-positive macropinosomes was observed after IQGAP1 siRNA treatment compared with cells treated with control siRNA (Fig. 9A). This is consistent with the idea that loss of IQGAP1 reduces targeting of beta-catenin to membrane ruffles, indirectly affecting its ability to be internalized through macropinocytosis. To further show that IQGAP1 regulates beta-catenin internalization, we transiently expressed different GFP-fusion proteins in NIH 3T3 cells. Overexpressed GFP-IQGAP1 increased the formation of beta-catenin-positive macropinosomes, whereas expression of the C-terminal dominant negative sequence of IQGAP1 (IQGAP1-ct) reduced beta-catenin macropinocytosis (Fig. 9B). The overexpression of GFP-N-cadherin had little effect on beta-catenin macropinosomes.

beta-Catenin Regulates Macropinocytosis of APC, IQGAP1, and N-cadherin—Does beta-catenin itself contribute to macropinocytosis? To address this question, NIH 3T3 cells were treated with control siRNA or beta-catenin siRNA to assess the impact of beta-catenin silencing on macropinosome formation. The beta-catenin siRNA treatment reduced visible beta-catenin-positive macropinosomes in cells by 84% compared with cells treated with control siRNA (Fig. 9C). It is interesting to note that this knockdown impacted modestly on the overall macropinocytosis process, as staining for actin-positive macropinosome particles was reduced by ~28% compared with control. More striking was the specific effect on the beta-catenin binding partners APC, N-cadherin, and IQGAP1; cells with visible staining of these partners at macropinosomes were reduced by 80-90% after beta-catenin siRNA treatment (Fig. 9C). In contrast, knockdown of beta-catenin had little effect on IQGAP1 staining at membrane ruffles (Fig. 5). These data imply a possible chaperone/scaffolding role for beta-catenin in the IQGAP1-dependent internalization of N-cadherin and APC.


Figure 8
View larger version (40K):
[in this window]
[in a new window]

 
FIGURE 8.
beta-Catenin co-localizes with actin, APC, IQGAP1, and N-cadherin at macropinosomes. NIH 3T3 cells were transfected with ASEF-ca and stained with antibodies to beta-catenin and the different partner proteins. Co-staining at macropinosomes was scored (see arrows in the cell images) and quantified. Values shown in graph are mean ± S.E. from two experiments.

 
beta-Catenin Macropinosomes Co-localize with the Lysosomal Marker, LAMP1, Identifying a Route for Protein Recycling—E-cadherin is internalized by different endocytosis pathways and was subsequently degraded or recycled back to the membrane, but much less is known about the internalization of beta-catenin (34-36). Internalized E-cadherin vesicles have been reported to co-localize with Rab5- and EEA1-positive early endosomes (34, 36, 37). Macropinosomes do not usually co-stain with markers of early or late endosomes, although the constituents can be recycled through these pathways after the macropinosome breaks down (17, 27). To confirm that the macropinosomes detected here are not an unusual form of vesicle, we stained for various endosomal markers but observed no co-localization with TGN38 (Golgi marker), EEA1, Rab3 and Rab5 (early endosome proteins), or Rab11 (recycling endosomes) using both standard fluorescence microscopy and deconvolution microscopy. All of the antibodies tested are well characterized and have been published for clear detection of their respective targets (see "Materials and Methods"), and all gave the expected vesicular or granular staining patterns as published. The only antibody tested that produced a pattern of co-localization with beta-catenin macropinosomes was the lysosomal marker, LAMP1 (Fig. 10A). Using a Zeiss Axiovert 200M microscope and deconvolution software, we found that 38% of beta-catenin macropinosomes co-localized with LAMP1 antibody (Fig. 10A). This finding is consistent with the ultimate merging of macropinosomes with the late endocytic machinery and suggests that beta-catenin-positive macropinosomes are eventually targeted for lysosome-mediated degradation, with the constituents presumably degraded or recycled for trafficking to other parts of the cell.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
beta-Catenin is a mediator of the wnt signaling pathway and is generally regarded to have two major sites of action in the cell; that is, at membrane adherens junctions and in the nucleus (1, 38). In this study we show that beta-catenin also accumulates at membrane ruffles in actively migrating cells and identified the beta-catenin binding partner, IQGAP1, as a key regulator of this process. IQGAP1 is known to modulate cell migration (11, 12), and the specific silencing of beta-catenin likewise displayed a reproducible, albeit modest, influence on the rate of cell migration. The main consequence of beta-catenin recruitment to membrane ruffles was its rapid internalization through ruffle-induced macropinocytosis. This macropinocytic pathway was regulated by Arf6 and IQGAP1. We propose, based on data reported in this study, that beta-catenin may act as a linker or scaffold for the IQGAP1-dependent internalization and recycling of specific binding partners including APC and N-cadherin (our findings are summarized in Fig. 10B). The concept of beta-catenin acting as a chaperone or scaffold for the internalization of membrane-associated proteins provides a new context for its targeting to these dynamic membrane regions.

beta-Catenin at Membrane Rufflesbeta-Catenin is usually described as an integral component of cell adherens junctions and plays a key role in the nucleus as a transcriptional regulator and activator of cell transformation in several cancers (3, 38). In addition to cell-cell membrane junctions, beta-catenin has been detected at other membrane locations including microtubule-dependent membrane protrusions (39) and actin-dependent membrane ruffles (10). We recently demonstrated a role for beta-catenin in regulating APC localization at membrane protrusions (20). Here we addressed the question of why beta-catenin localized to membrane ruffles. First, we tested its involvement in cell migration by imaging live cells after wounding and tracking the rate of wound closure in NIH 3T3 fibroblasts transfected with control siRNA or beta-catenin siRNA. The silencing of beta-catenin delayed the initiation process of wound closure for up to 4-6 h but thereafter did not affect the rate of cell migration significantly. To our knowledge this is the first study to test the impact of beta-catenin knock-down on fibroblast cell migration. Wong and Gumbiner (23) silenced beta-catenin in breast tumor epithelial cells and observed a reduction in in vitro invasive ability, but the impact on cell migration was not appraised directly. The knockdown of beta-catenin in endothelial cells had the opposite effect and increased entry of cells into the wound (40). Previous work with fibroblasts has shown, however, that the overexpression of beta-catenin in fibroblasts can directly stimulate both in vitro cell migration and invasiveness (41). Because the overexpression of beta-catenin also correlates with increased transcriptional activity, it remains difficult to conclude whether beta-catenin influences cell movement directly by its membrane ruffle localization and/or indirectly through its nuclear transcription function.


Figure 9
View larger version (47K):
[in this window]
[in a new window]

 
FIGURE 9.
IQGAP1 and beta-catenin regulate macropinocytosis of partner proteins. A, NIH 3T3 cells were transfected with control or IQGAP1 siRNA, and >200 cells were scored for the presence of beta-catenin or IQGAP1 at macropinosomes. B, cells were transfected with plasmids encoding GFP-fusions of N-cadherin or IQGAP1 (wild-type or ct mutant) and co-stained for beta-catenin. The proportion of transfected cells with beta-catenin-positive macropinosomes was scored and graphed. Data are the mean ± S.E. from two experiments. C, cells were transfected with control or beta-catenin siRNA, then stained for beta-catenin and partner proteins and processed for microscopy. Cells were scored randomly for the presence of beta-catenin or partner at macropinosomes. The data shown are the mean ± S.E. from three experiments. The loss of beta-catenin reduced staining of partners at macropinosomes.

 
We addressed the mechanism by which beta-catenin is recruited to membrane ruffles, noting that the primary beta-catenin binding partner, APC, is recruited to membrane ruffles by direct interaction with IQGAP1 (11). IQGAP1, an effector of Cdc42 and Rac1 GTPases and an actin-binding protein (22), binds to the N-terminal region (amino acids 47-217) of beta-catenin (24). We used deletion mapping to identify the critical membrane ruffle-targeting sequence of beta-catenin and found that deletion of the IQGAP1 binding domain, but not the binding site for APC or cadherins, diminished movement of beta-catenin to ruffles. To show that IQGAP1 contributed to beta-catenin membrane localization, we knocked down IQGAP1 expression by RNA interference and confirmed that loss of IQGAP1 impaired the staining of beta-catenin at membrane ruffles (see Fig. 4). Conversely, the overexpression of either IQGAP1 or N-cadherin increased beta-catenin at membrane ruffles. IQGAP1 is an important regulator of cell migration (11, 12) and adhesion (22, 42), and its binding to beta-catenin may modulate these processes. In this regard it was proposed that direct binding of IQGAP1 to beta-catenin-E-cadherin complexes at epithelial cell adherens junctions may displace {alpha}-catenin and actin, leading to weakening of the adherens junction and a consequent increase in cell movement (42). On the other hand, our data with fibroblasts implicate an association between beta-catenin and IQGAP1 at membrane ruffles that might also favor cell migration, a view supported by the negative influence on migration by siRNA-mediated knockdown of IQGAP1 (11, 12), APC (11), and beta-catenin (this study).

IQGAP1-dependent Macropinocytosis of beta-Catenin—Membrane ruffling is also important for solute uptake by macropinocytosis. A key finding of this study is that IQGAP1-dependent recruitment of beta-catenin to membrane ruffles facilitates the macropinocytosis of beta-catenin and specific binding partners. Ruffle-mediated macropinocytosis provides a mechanism for internalizing large sections of lateral plasma membrane in an actin-dependent but clathrin-independent manner (25, 26, 43). We stimulated membrane ruffle formation by overexpressing the ASEF GTPase exchange factor and observed an increase in beta-catenin macropinosome formation. Consistent with other studies (28, 29), this process was regulated by Arf6 GTPase. Moreover, the knockdown or competitive inhibition of IQGAP1 diminished beta-catenin macropinocytosis. It is not yet known whether IQGAP1 regulates beta-catenin endocytosis in fibroblast cells.


Figure 10
View larger version (47K):
[in this window]
[in a new window]

 
FIGURE 10.
beta-Catenin macropinosomes co-localize with the lysosomal marker, LAMP1. A, NIH 3T3 cells were transfected with ASEF-ca plasmid and stained with antibodies against beta-catenin and various endocytic markers. Co-localization was first assessed by standard fluorescence microscopy, and then a minimum of 11 cell images for each sample were captured as z-stacks and analyzed by deconvolution software to determine co-localization within the cell. The only antibody to co-stain beta-catenin-positive macropinosomes was LAMP1, and 38% of cells analyzed showed co-staining within the cytoplasm. This indicates that the macropinosomes are targeted to the lysosome. B, diagram summarizing the data from siRNA and transient expression assays in this study. Proteins (effectors) that stimulated the localization of specific proteins to membrane ruffles or to macropinosomes are indicated.

 
The depletion of beta-catenin at membrane ruffles by siRNA significantly reduced macropinocytosis of the associating proteins IQGAP1, APC, and N-cadherin from membrane ruffles. Silencing of beta-catenin did not, however, affect IQGAP1 staining at membrane ruffles, which clearly places IQGAP1 as an upstream regulator of membrane-associated beta-catenin. Our findings (see Fig. 10B) implicate a novel function of beta-catenin; that is, the regulated internalization of membrane ruffle-associated APC and N-cadherin. Once internalized, these proteins may subsequently follow the endocytic pathway for membrane proteins where they are targeted for recycling or degradation (44). This is suggested by our observation that some beta-catenin macropinosomes co-stained with the lysosome marker LAMP1, indicating that they are targeted for lysosome mediated degradation.

The cadherins are a family of transmembrane proteins that display variable cellular distribution and function in different cell types. E-cadherin is highly expressed in epithelial cells and promotes cell-cell adhesion (45, 46), whereas N-cadherin is implicated in promoting cell motility and invasion (23, 47, 48). Paterson et al. (29) previously speculated that E-cadherin might be internalized by active macropinocytosis in MCF-7 breast cancer cells, but this was not experimentally verified. In this study N-cadherin co-localized strongly with beta-catenin in NIH 3T3 cells at both adhering and ruffling membrane, in the cytoplasm in macropinosomes, and to a lesser degree in the nucleus (data not shown). It is possible that the two form an intracellular complex important for regulating their cellular targeting, at least for their co-location at membrane ruffles and their internalization by macropinocytosis as demonstrated here. Indeed, the overexpression of N-cadherin contributed to beta-catenin recruitment at membrane ruffles, and knockdown of beta-catenin reduced N-cadherin at ruffles, predicting that the two proteins may form a mutual complex with IQGAP1 at actin filaments just below the membrane surface. Our data implicate beta-catenin as an intermediate in the IQGAP1-regulated internalization of APC and N-cadherin by macropinocytosis.

Although Rac1 is essential for membrane ruffle formation (49), other small GTPases such as Rah/Rab34 have been implicated in the generation of macropinosomes from ruffled membrane (33). We detected actin in most, but not all beta-catenin-positive macropinosomes, and this is consistent with the notion that actin coats the macropinosome but comes off as the vesicles move toward the center of the cell (33). There is very little known in regard to internalization and recycling of IQGAP1, N-cadherin, or APC, and it is tempting to speculate that one reason beta-catenin moves to this dynamic membrane region is to help facilitate the internalization of these factors. It is yet to be determined if beta-catenin moves to ruffles from a defined pool, although its targeting does not seem to be regulated by phosphorylation (Fig. 3 and data not shown). Further study of these questions should help elucidate new roles for membrane associated beta-catenin.


    FOOTNOTES
 
* This work was generously supported by grants from the New South Wales Cancer Council, the Australian Research Council, and the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1—S6. Back

1 A Senior Research Fellow of the National Health and Medical Research Council of Australia. To whom correspondence should be addressed: Westmead Millennium Institute, Darcy Rd., P. O. Box 412, Westmead, NSW 2145, Australia. Tel.: 61-2-9845-9057; Fax: 61-2-9845-9102; E-mail: beric_henderson{at}wmi.usyd.edu.au.

2 The abbreviations used are: APC, adenomatous polyposis coli; ASEF, APC-stimulated exchange factor; GFP, green fluorescent protein; IQGAP1, IQ-domain GTPase-activating protein 1; LAMP1, lysosome-associated membrane protein 1; PBS, phosphate-buffered saline; siRNA, small interference RNA; ca, constitutively active; wt, wild type; ct, C terminus; HA, hemagglutinin; TRITC, tetramethylrhodamine isothiocyanate; FITC, fluorescein isothiocyanate. Back


    ACKNOWLEDGMENTS
 
We are extremely grateful for the generosity of Drs. Julie Donaldson, Jenny Stow, Phil Robinson, Rob Parton, Mark Philips, Cécile Gauthier-Rouvière, and Alpha Yap in supplying plasmids and antibody reagents. We thank Dr. Alpha Yap for early discussions about the macropinocytosis pathway and Michael Johnson for technical assistance.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Polakis, P. (2000) Genes Dev. 14, 1837-1851[Free Full Text]
  2. Gumbiner, B. M. (2000) J. Cell Biol. 148, 399-403[Abstract/Free Full Text]
  3. Lustig, B., and Behrens, J. (2003) J. Cancer Res. Clin. Oncol. 129, 199-221[Medline] [Order article via Infotrieve]
  4. Henderson, B. R., and Fagotto, F. (2002) EMBO Rep. 3, 834-839[CrossRef][Medline] [Order article via Infotrieve]
  5. Yap, A., Brieher, W. M., and Gumbiner, B. M. (1997) Annu. Rev. Cell Dev. Biol. 13, 119-146[CrossRef][Medline] [Order article via Infotrieve]
  6. Adams, C. A., Chen, Y. T., Smith, S. J., and Nelson, W. J. (1998) J. Cell Biol. 142, 1105-1119[Abstract/Free Full Text]
  7. Wheelock, M. J., Soler, A. P., and Knudsen, K. A. (2001) J. Mammary Gland Biol. Neoplasia 6, 275-285[CrossRef][Medline] [Order article via Infotrieve]
  8. Thiery, J. P. (2002) Nat. Rev. Cancer 2, 442-454[CrossRef][Medline] [Order article via Infotrieve]
  9. Conacci-Sorrell, M., Zhurinsky, J., and Ben-Ze'ev, A. (2002) J. Clin. Investig. 109, 987-991[CrossRef][Medline] [Order article via Infotrieve]
  10. Etienne-Manneville, S., and Hall, A. (2003) Nature 421, 753-756[CrossRef][Medline] [Order article via Infotrieve]
  11. Watanabe, T., Wang, S., Noritake, J., Sato, K., Fukata, M., Takefuji, M., Nakagawa, M., Izumi, N., Akiyama, T., and Kaibuchi, K. (2004) Dev. Cell 7, 871-883[CrossRef][Medline] [Order article via Infotrieve]
  12. Mataraza, J. M., Briggs, M. W., Li, Z., Entwistle, A., Ridley, A. J., and Sacks, D. B. (2003) J. Biol. Chem. 278, 41237-41245[Abstract/Free Full Text]
  13. Michaelson, D., Silletti, J., Murphy, G., Eustachio, P. D., Rush, M., and Phillips, M. R. (2001) J. Cell Biol. 152, 111-126[Abstract/Free Full Text]
  14. Kawasaki, Y., Senda, T., Ishdate, T., Koyama, R., Morishita, T., Iwayama, Y., Higuchi, O., and Akiyama, T. (2000) Science 289, 1194-1197[Abstract/Free Full Text]
  15. Kawasaki, Y., Sato, R., and Akiyama, T. (2003) Nat. Cell Biol. 5, 211-215[CrossRef][Medline] [Order article via Infotrieve]
  16. Kolligs, F., Hu, G., Dang, C. V., and Fearon, E. R. (1999) Mol. Cell. Biol. 19, 5696-5706[Abstract/Free Full Text]
  17. Schafer, D. A., D'Souza-Schorey, C., and Cooper, J. A. (2000) Traffic 1, 892-903[Medline] [Order article via Infotrieve]
  18. Henderson, B. R. (2000) Nat. Cell Biol. 2, 653-660[CrossRef][Medline] [Order article via Infotrieve]
  19. Eleftheriou, A., Yoshida, M., and Henderson, B. R. (2001) J. Biol. Chem. 276, 25883-25888[Abstract/Free Full Text]
  20. Sharma, M., Leung, L., Brocardo, M., Henderson, J., Flegg, C., and Henderson, B. R. (2006) J. Biol. Chem. 281, 17140-17149[Abstract/Free Full Text]
  21. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. (1992) Cell 70, 401-410[CrossRef][Medline] [Order article via Infotrieve]
  22. Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K. (1998) Science 281, 832-835[Abstract/Free Full Text]
  23. Wong, A. S. T., and Gumbiner, B. M (2003) J. Cell Biol. 161, 1191-1203[Abstract/Free Full Text]
  24. Fukata, M., Kuroda, S., Nakagawa, M., Kawajiri, A., Itoh, N., Shoji, I., Yoshiharu, M., Yonehara, S., Fujisawa, H., Kikuchi, A., and Kaibuchi, K (1999) J. Biol. Chem. 274, 26044-26050[Abstract/Free Full Text]
  25. Swanson, J. A., and Watts, C. (1995) Trends Cell Biol. 5, 424-428[CrossRef][Medline] [Order article via Infotrieve]
  26. Cardelli, J. (2001) Traffic 2, 311-320[CrossRef][Medline] [Order article via Infotrieve]
  27. Donaldson, J. G. (2003) J. Biol. Chem. 278, 41573-41576[Free Full Text]
  28. Palacois, F., Price, L., Schweiter, J., Collard, J. G., and D'Souza-Schorey, C. (2001) EMBO J. 20, 4973-4986[CrossRef][Medline] [Order article via Infotrieve]
  29. Paterson, A., Parton, R. G., Ferguson, C., Stow, J. L., and Yap, A. (2003) J. Biol. Chem. 278, 21050-21057[Abstract/Free Full Text]
  30. Bar-Sagi, D., and Feramisco, J. R. (1986) Science 233, 1061-1068[Abstract/Free Full Text]
  31. Mukherjee, S., Gurevich, V. V., Jones, J. C. R., Casanova, J. E., Frank, S. R., Maizels, E., Bader, M. F., Kahn, K., Palczewski, K., Aktories, K., and Hunzicker-Dunn, M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 5901-5906[Abstract/Free Full Text]
  32. Le Stunff, H., Dokhac, L., Bourgoin, S., Bader, M. F., and Harbon, S. (2000) Biochem. J. 352, 491-499
  33. Sun, P., Yamamoto, H., Suetsugu, S., Miki, H., Takenawa, T., and Endo, T. (2003) J. Biol. Chem. 278, 4063-4071[Abstract/Free Full Text]
  34. Le, T. L., Yap, A., and Stow, J. L. (1999) J. Cell Biol. 146, 219-232[Abstract/Free Full Text]
  35. Le, T. L., Joseph, S., Yap, A., and Stow, J. L. (2002) Am. J. Physiol. Cell Physiol. 283, 489-499
  36. Fujita, Y., Kraus, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., and Birchmeier, W. (2002) Nat. Cell Biol. 4, 222-231[CrossRef][Medline] [Order article via Infotrieve]
  37. Ivanov, A. I., Nusrat, A., and Parkos, C. A. (2004) Mol. Biol. Cell 15, 176-188[Abstract/Free Full Text]
  38. Polakis, P. (2001) Cell 105, 563-566[CrossRef][Medline] [Order article via Infotrieve]
  39. Nathke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., and Nelson, W. J. (1996) J. Cell Biol. 134, 165-179[Abstract/Free Full Text]
  40. Cattelino, A., Leibner, S., Gallini, R., Zanetti, A., Balconi, G., Corsi, A., Bianco, P., Wolburg, H., Moore, R., Oreda, B., Kemler, R., and Dejana, E. (2002) J. Cell Biol. 162, 1111-1122
  41. Cheon, S. S., Cheah, A. Y., Turley, S., Nadesan, P., Poon, R., Clevers, H., and Alman, B. A. (2002) Proc. Natl. Acad. Sci. 99, 6973-6978[Abstract/Free Full Text]
  42. Noritake, J., Fukata, M., Sato, K., Nakagawa, M., Watanabe, T., Izumi, N., Wang, S., Fukata, Y., and Kaibuchi, K. (2004) Mol. Biol. Cell 15, 1065-1076[Abstract/Free Full Text]
  43. Kirkham, M., and Parton, R. G. (2005) Biochim. Biophys Acta 1745, 273-286[Medline] [Order article via Infotrieve]
  44. Pece, S., and Gutkind, J. S. (2002) Nat. Cell Biol. 4, 72-74
  45. Takeichi, M. (1995) Curr. Opin. Cell Biol. 7, 619-627[CrossRef][Medline] [Order article via Infotrieve]
  46. Cavallaro, U., Schaffhauser, B., and Christofori, G. (2002) Cancer Lett. 176, 123-126[CrossRef][Medline] [Order article via Infotrieve]
  47. Islam, S., Carey, T. E., Wolf, G. T., Wheelock, M. J., and Johnson, K. R. (1996) J. Cell Biol. 135, 1643-1654[Abstract/Free Full Text]
  48. Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., and Arranson, L. A. (2000) J. Cell Biol. 148, 779-790[Abstract/Free Full Text]
  49. Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T., and Horwitz, A. R. (2003) Science 302, 1704-1709[Abstract/Free Full Text]
  50. Mary, S., Charrasse, S., Meriane, M., Comunale, F., Travo, P., Blangy, A., and Gauthier-Rouvière, C. (2002) Mol. Biol. Cell 13, 285-301[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Hu, B. Shi, M. J. Jarzynka, J.-J. Yiin, C. D'Souza-Schorey, and S.-Y. Cheng
ADP-Ribosylation Factor 6 Regulates Glioma Cell Invasion through the IQ-Domain GTPase-Activating Protein 1-Rac1-Mediated Pathway
Cancer Res., February 1, 2009; 69(3): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. L. Nachman and S. Rafii
Platelets, Petechiae, and Preservation of the Vascular Wall
N. Engl. J. Med., September 18, 2008; 359(12): 1261 - 1270.
[Full Text] [PDF]


Home page
Sci SignalHome page
Y. A. Komarova, D. Mehta, and A. B. Malik
Dual Regulation of Endothelial Junctional Permeability
Sci. Signal., November 13, 2007; 2007(412): re8 - re8.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Boca, L. D'Amato, G. Distefano, R. S. Polishchuk, G. G. Germino, and A. Boletta
Polycystin-1 Induces Cell Migration by Regulating Phosphatidylinositol 3-kinase-dependent Cytoskeletal Rearrangements and GSK3beta-dependent Cell Cell Mechanical Adhesion
Mol. Biol. Cell, October 1, 2007; 18(10): 4050 - 4061.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/11/8545    most recent
M610272200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, M.
Right arrow Articles by Henderson, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, M.
Right arrow Articles by Henderson, B. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement